FLT3-ITD gene mutation in AML patients was associated with blast cell count, CD34 and cyclin D1 expression, therefore it supports the role of FLT3-ITD gene mutation in excessive proliferation activity responsible for the pathogenesis of AML. Here, CD34 is linked to acute myeloid leukemia.